Looking at the last two appendix 4cs. I can the figures are building up nicely.
Now add dapsone gel line to it we should see the figures are going up significantly.
Cash flow should be positive as of next quarter. Cash reserves looks healthy too, should be $10 to 15 millions by EFY equal to market cap now.
IMC with half of ACR revenue with barely significant products has twice the market cap of ACR.
I m fair to say, ACR will have a lot of positive upside from here once market realises its financial position.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
-0.001(5.56%) |
Mkt cap ! $6.957M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.7¢ | $39.01K | 2.195M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 993954 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 435000 | 1 |
View Market Depth
| Last trade - 14.23pm 31/07/2025 (20 minute delay) ? |
| ACR (ASX) Chart |